Clinical Trial Update: Characterizing a 5P-Linked BHR Susceptibility Locus

View source ↗

Summary

This clinical trial update characterizes a 5P-linked locus associated with bronchial hyperresponsiveness in asthma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Snippet

Sponsor: University of Chicago | Conditions: Asthma, Lung Diseases | Status: COMPLETED